Solid Biosciences Inc (SLDB)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-13 | 2025-03-11 | B Purchase | Non-Executive Director |
1,860
+169.1%
5.34USD 9,924 |
1,860 +169.1% | 5.34 | USD 9,924 | |
| 2025-02-21 | 2025-02-19 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
1,000,000
+24.8%
4.03USD 4,030,000 |
1,000,000 +24.8% | 4.03 | USD 4,030,000 | |
| 2025-02-21 | 2025-02-19 | B Purchase | Non-Executive Director Large shareholder |
5,000,000
+73.2%
4.03USD 20,150,000 |
5,000,000 +73.2% | 4.03 | USD 20,150,000 | |
| 2025-02-19 | 2025-02-18 | B Purchase |
Adage Capital Management, L.P. Large shareholder |
252,545
+6.3%
7.56USD 1,909,240 |
252,545 +6.3% | 7.56 | USD 1,909,240 | |
| 2025-02-18 | 2025-02-14 | S Sale |
CFO & Treasurer Officer |
3,164
-8.9%
3.96USD 12,529 |
3,164 -8.9% | 3.96 | USD 12,529 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Operating Officer Officer |
5,561
-18.3%
3.96USD 22,022 |
5,561 -18.3% | 3.96 | USD 22,022 | |
| 2025-02-18 | 2025-02-14 | S Sale | Non-Executive Director |
1,711
-10.3%
3.96USD 6,776 |
1,711 -10.3% | 3.96 | USD 6,776 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Regulatory Officer Officer |
3,079
-13.8%
3.96USD 12,193 |
3,079 -13.8% | 3.96 | USD 12,193 | |
| 2025-02-18 | 2025-02-14 | S Sale |
President and CEO Executive Director |
11,365
-15.8%
3.96USD 45,005 |
11,365 -15.8% | 3.96 | USD 45,005 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Medical Officer Officer |
3,256
-12.5%
3.96USD 12,894 |
3,256 -12.5% | 3.96 | USD 12,894 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Technology Officer Officer |
2,688
-12.8%
3.96USD 10,644 |
2,688 -12.8% | 3.96 | USD 10,644 | |
| 2025-01-29 | 2025-01-28 | S Sale | Non-Executive Director |
144
-1.2%
3.11USD 448 |
144 -1.2% | 3.11 | USD 448 | |
| 2025-01-13 | 2025-01-10 | PS Planned sale |
CFO & Treasurer Officer |
4,073
-14.1%
3.89USD 15,849 |
4,073 -14.1% | 3.89 | USD 15,849 | |
| 2025-01-07 | 2025-01-06 | S Sale | Non-Executive Director |
1,056
-8.4%
4.31USD 4,551 |
1,056 -8.4% | 4.31 | USD 4,551 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Regulatory Officer Officer |
4,610
-24.5%
5.60USD 25,822 |
4,610 -24.5% | 5.60 | USD 25,822 | |
| 2024-12-04 | 2024-12-03 | S Sale |
President and CEO Executive Director |
11,114
-22.4%
5.60USD 62,236 |
11,114 -22.4% | 5.60 | USD 62,236 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Operating Officer Officer |
5,072
-24.5%
5.60USD 28,396 |
5,072 -24.5% | 5.60 | USD 28,396 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Technology Officer Officer |
2,777
-18.6%
5.60USD 15,551 |
2,777 -18.6% | 5.60 | USD 15,551 | |
| 2024-10-22 | 2024-10-21 | S Sale |
Chief Medical Officer Officer |
2,923
-21.0%
6.50USD 19,000 |
2,923 -21.0% | 6.50 | USD 19,000 | |
| 2024-06-11 | 2024-06-07 | B Purchase | Non-Executive Director |
1,100
+inf%
7.67USD 8,442 |
1,100 +inf% | 7.67 | USD 8,442 | |
| 2024-05-06 | 2024-05-02 | S Sale | Non-Executive Director |
462
-4.6%
10.33USD 4,772 |
462 -4.6% | 10.33 | USD 4,772 | |
| 2024-01-30 | 2024-01-29 | S Sale | Non-Executive Director |
139
-1.6%
7.99USD 1,111 |
139 -1.6% | 7.99 | USD 1,111 | |
| 2024-01-12 | 2024-01-11 | B Purchase | Non-Executive Director Large shareholder |
3,410,713
+99.6%
5.53USD 18,861,243 |
3,410,713 +99.6% | 5.53 | USD 18,861,243 | |
| 2024-01-12 | 2024-01-11 | B Purchase | Non-Executive Director Large shareholder |
904,160
+27.5%
5.53USD 5,000,005 |
904,160 +27.5% | 5.53 | USD 5,000,005 | |
| 2024-01-11 | 2024-01-09 | PS Planned sale |
CFO & Treasurer Officer |
3,935
-29.7%
8.20USD 32,267 |
3,935 -29.7% | 8.20 | USD 32,267 | |
| 2024-01-05 | 2024-01-03 | S Sale | Non-Executive Director |
1,142
-12.3%
5.30USD 6,052 |
1,142 -12.3% | 5.30 | USD 6,052 | |
| 2023-12-05 | 2023-12-04 | PS Planned sale |
Chief Operating Officer Officer |
5,367
-41.1%
2.78USD 14,920 |
5,367 -41.1% | 2.78 | USD 14,920 | |
| 2023-12-05 | 2023-12-04 | PS Planned sale |
CSO Officer |
4,890
-41.1%
2.77USD 13,525 |
4,890 -41.1% | 2.77 | USD 13,525 | |
| 2023-12-05 | 2023-12-04 | PS Planned sale |
Chief Technology Officer Officer |
2,968
-41.0%
2.77USD 8,232 |
2,968 -41.0% | 2.77 | USD 8,232 | |
| 2023-12-05 | 2023-12-04 | PS Planned sale |
Chief Regulatory Officer Officer |
4,879
-41.1%
2.78USD 13,562 |
4,879 -41.1% | 2.78 | USD 13,562 | |
| 2023-12-05 | 2023-12-04 | PS Planned sale |
President and CEO Executive Director |
11,757
-40.3%
2.77USD 32,516 |
11,757 -40.3% | 2.77 | USD 32,516 | |
| 2023-06-08 | 2023-05-02 | PS Planned sale | Non-Executive Director |
487
-10.5%
4.85USD 2,364 |
487 -10.5% | 4.85 | USD 2,364 | |
| 2023-01-31 | 2023-01-27 | PS Planned sale |
Chief Scientific Officer Officer |
441
-2.2%
7.49USD 3,303 |
441 -2.2% | 7.49 | USD 3,303 | |
| 2023-01-31 | 2023-01-27 | PS Planned sale | Non-Executive Director |
1,382
-1.6%
7.49USD 10,351 |
1,382 -1.6% | 7.49 | USD 10,351 | |
| 2023-01-31 | 2023-01-27 | PS Planned sale | Non-Executive Director |
141
-9.3%
7.49USD 1,056 |
141 -9.3% | 7.49 | USD 1,056 | |
| 2022-03-15 | 2022-03-14 | PS Planned sale |
Chief Operating Officer Officer |
15,272
-6.1%
1.10USD 16,799 |
15,272 -6.1% | 1.10 | USD 16,799 | |
| 2022-03-15 | 2022-03-14 | PS Planned sale |
Chief Operating Officer Officer |
15,232
-5.7%
1.10USD 16,755 |
15,232 -5.7% | 1.10 | USD 16,755 | |
| 2022-03-15 | 2022-03-14 | PS Planned sale |
Chief Scientific Officer Officer |
11,396
-4.3%
1.10USD 12,536 |
11,396 -4.3% | 1.10 | USD 12,536 | |
| 2022-03-15 | 2022-03-14 | PS Planned sale |
Chief Scientific Officer Officer |
11,269
-4.1%
1.10USD 12,396 |
11,269 -4.1% | 1.10 | USD 12,396 | |
| 2022-03-08 | 2022-02-10 | PS Planned sale |
CEO & President Executive Director |
463
-15.5%
1.12USD 519 |
463 -15.5% | 1.12 | USD 519 | |
| 2021-03-23 | 2021-03-23 | B Purchase | Non-Executive Director Large shareholder |
2,608,695
+24.1%
5.75USD 14,999,996 |
2,608,695 +24.1% | 5.75 | USD 14,999,996 | |
| 2021-03-23 | 2021-03-19 | B Purchase | Non-Executive Director Large shareholder |
2,206,685
+25.3%
5.75USD 12,688,439 |
2,206,685 +25.3% | 5.75 | USD 12,688,439 | |
| 2021-03-15 | 2021-03-12 | PS Planned sale |
Chief Scientific Officer Officer |
11,699
-4.1%
8.85USD 103,488 |
11,699 -4.1% | 8.85 | USD 103,488 | |
| 2021-03-15 | 2021-03-12 | PS Planned sale |
Chief Operating Officer Officer |
11,699
-4.2%
8.84USD 103,452 |
11,699 -4.2% | 8.84 | USD 103,452 | |
| 2021-03-15 | 2021-03-12 | PS Planned sale |
Chief Scientific Officer Officer |
11,699
-3.9%
8.84USD 103,459 |
11,699 -3.9% | 8.84 | USD 103,459 | |
| 2021-03-15 | 2021-03-12 | PS Planned sale |
Chief Operating Officer Officer |
11,699
-4.0%
8.84USD 103,468 |
11,699 -4.0% | 8.84 | USD 103,468 | |
| 2021-02-16 | 2021-02-12 | S Sale |
CEO & President Executive Director |
457
-13.1%
7.66USD 3,501 |
457 -13.1% | 7.66 | USD 3,501 | |
| 2021-01-29 | 2021-01-28 | S Sale |
CFO, Treasurer & Asst. Secy Officer |
3,473
-1.0%
6.14USD 21,327 |
3,473 -1.0% | 6.14 | USD 21,327 | |
| 2021-01-29 | 2021-01-28 | S Sale |
CEO & President Executive Director |
10,713
-0.9%
6.14USD 65,776 |
10,713 -0.9% | 6.14 | USD 65,776 | |
| 2021-01-29 | 2021-01-28 | S Sale |
Chief Technology Officer Officer |
3,443
-1.2%
6.14USD 21,145 |
3,443 -1.2% | 6.14 | USD 21,145 | |
| 2021-01-29 | 2021-01-28 | S Sale |
Chief Scientific Officer Officer |
3,459
-1.1%
6.14USD 21,238 |
3,459 -1.1% | 6.14 | USD 21,238 | |
| 2020-08-14 | 2020-08-13 | S Sale |
CEO & President Executive Director |
299
-7.9%
2.44USD 730 |
299 -7.9% | 2.44 | USD 730 | |
| 2020-07-29 | 2020-07-28 | S Sale |
Chief Scientific Officer Officer |
3,591
-1.2%
2.42USD 8,689 |
3,591 -1.2% | 2.42 | USD 8,689 | |
| 2020-07-29 | 2020-07-28 | S Sale |
Chief Technology Officer Officer |
4,041
-1.4%
2.42USD 9,776 |
4,041 -1.4% | 2.42 | USD 9,776 | |
| 2020-07-29 | 2020-07-28 | S Sale |
Chief Legal Officer Officer |
5,141
-3.1%
2.42USD 12,438 |
5,141 -3.1% | 2.42 | USD 12,438 | |
| 2020-07-29 | 2020-07-28 | S Sale |
CEO & President Executive Director |
11,124
-1.0%
2.42USD 26,910 |
11,124 -1.0% | 2.42 | USD 26,910 | |
| 2020-07-29 | 2020-07-28 | S Sale |
CFO, Treasurer & Asst. Secy Officer |
3,591
-1.1%
2.42USD 8,687 |
3,591 -1.1% | 2.42 | USD 8,687 | |
| 2019-07-29 | 2019-07-25 | B Purchase | Large shareholder |
2,822,581
+71.9%
4.65USD 13,125,002 |
2,822,581 +71.9% | 4.65 | USD 13,125,002 | |
| 2019-05-10 | 2019-05-08 | PS Planned sale |
8,000
-44.0%
10.00USD 80,039 |
8,000 -44.0% | 10.00 | USD 80,039 | ||
| 2019-03-28 | 2019-03-28 | S Sale | Large shareholder |
60,000
-1.7%
9.53USD 571,800 |
60,000 -1.7% | 9.53 | USD 571,800 | |
| 2019-03-28 | 2019-03-27 | S Sale | Large shareholder |
115,000
-3.2%
9.60USD 1,104,000 |
115,000 -3.2% | 9.60 | USD 1,104,000 | |
| 2019-03-28 | 2019-03-26 | S Sale | Large shareholder |
275,000
-7.0%
10.08USD 2,772,000 |
275,000 -7.0% | 10.08 | USD 2,772,000 | |
| 2019-01-16 | 2019-01-14 | PS Planned sale | Non-Executive Director |
3,300
-0.1%
32.20USD 106,258 |
3,300 -0.1% | 32.20 | USD 106,258 | |
| 2019-01-16 | 2019-01-14 | PS Planned sale | Non-Executive Director |
1,700
-0.1%
31.60USD 53,724 |
1,700 -0.1% | 31.60 | USD 53,724 | |
| 2019-01-08 | 2019-01-07 | PS Planned sale | Non-Executive Director |
5,000
-0.1%
30.08USD 150,407 |
5,000 -0.1% | 30.08 | USD 150,407 | |
| 2019-01-08 | 2019-01-04 | PS Planned sale |
Chief Operating Officer Officer |
9,000
-5.4%
30.07USD 270,619 |
9,000 -5.4% | 30.07 | USD 270,619 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Amorrortu Pedro Alvaro Chief Operating Officer Officer |
300
-0.2%
32.38USD 9,715 |
300 -0.2% | 32.38 | USD 9,715 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Amorrortu Pedro Alvaro Chief Operating Officer Officer |
5,693
-3.3%
31.44USD 178,996 |
5,693 -3.3% | 31.44 | USD 178,996 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Amorrortu Pedro Alvaro Chief Operating Officer Officer |
3,007
-1.7%
30.20USD 90,823 |
3,007 -1.7% | 30.20 | USD 90,823 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Quiroz Jorge Armando Chief Medical Officer Officer |
1,370
-0.6%
32.24USD 44,174 |
1,370 -0.6% | 32.24 | USD 44,174 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Quiroz Jorge Armando Chief Medical Officer Officer |
31,426
-12.0%
31.41USD 987,147 |
31,426 -12.0% | 31.41 | USD 987,147 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Quiroz Jorge Armando Chief Medical Officer Officer |
6,154
-2.3%
30.21USD 185,900 |
6,154 -2.3% | 30.21 | USD 185,900 | |
| 2018-12-04 | 2018-12-03 | PS Planned sale |
Quiroz Jorge Armando Chief Medical Officer Officer |
1,200
-0.4%
29.94USD 35,924 |
1,200 -0.4% | 29.94 | USD 35,924 | |
| 2018-11-20 | 2018-11-16 | PS Planned sale |
Quiroz Jorge Armando Chief Medical Officer Officer |
100
-0.0%
34.90USD 3,490 |
100 -0.0% | 34.90 | USD 3,490 | |
| 2018-11-20 | 2018-11-16 | PS Planned sale |
Zarur Juan Andrey Non-Executive Director |
100
-0.0%
35.00USD 3,500 |
100 -0.0% | 35.00 | USD 3,500 |